Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2026-01-04 @ 9:41 PM
Study NCT ID:
NCT01476657
Status:
TERMINATED
Last Update Posted:
2021-03-17
First Post:
2011-11-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Study of Duvelisib in Patients With Advanced Hematologic Malignancies
Sponsor:
SecuraBio
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
IPI-145-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None